In breast cancer, the induction of HO-1 and its catalyzed byproduct, CO, by CUR can attenuate heat shock protein (HSP) 90 activity and its client proteins Akt, CDK4, and cyclinD1 to further suppress the invasion and proliferation of cells [44]. This evidence concerns the gene AKT1 and breast carcinoma.